According to Swedish Orphan Biovitrum's latest financial reports the company has HK$0.80 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$0.80 B | 14.51% |
2023-12-31 | HK$0.70 B | -31.45% |
2022-12-31 | HK$1.02 B | 13.54% |
2021-12-31 | HK$0.90 B | 135.5% |
2020-12-31 | HK$0.38 B | -37.73% |
2019-12-31 | HK$0.61 B | -76.51% |
2018-12-31 | HK$2.61 B | 85.19% |
2017-12-31 | HK$1.41 B | 110.47% |
2016-12-31 | HK$0.67 B | -19.44% |
2015-12-31 | HK$0.83 B | 60.35% |
2014-12-31 | HK$0.51 B | -3.52% |
2013-12-31 | HK$0.53 B | -1.18% |
2012-12-31 | HK$0.54 B | 120.2% |
2011-12-31 | HK$0.24 B | 457.64% |
2010-12-31 | HK$44.36 M | -86.79% |
2009-12-31 | HK$0.33 B | -26.02% |
2008-12-31 | HK$0.45 B | -50.54% |
2007-12-31 | HK$0.91 B | -10.67% |
2006-12-31 | HK$1.02 B | -0.35% |
2005-12-31 | HK$1.03 B | -15.94% |
2004-12-31 | HK$1.22 B | 842.61% |
2003-12-31 | HK$0.13 B | 37.38% |
2002-12-31 | HK$94.71 M |